Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cx11
2. 5-[[(1-cyclopentyl-3-piperidyl)methyl-[2-(1-piperidyl)ethyl]amino]methyl]-2-methoxy-phenol
| Molecular Weight | 429.6 g/mol |
|---|---|
| Molecular Formula | C26H43N3O2 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 39.2 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 507 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
30
PharmaCompass offers a list of CX11 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CX11 manufacturer or CX11 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CX11 manufacturer or CX11 supplier.
PharmaCompass also assists you with knowing the CX11 API Price utilized in the formulation of products. CX11 API Price is not always fixed or binding as the CX11 Price is obtained through a variety of data sources. The CX11 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CX11 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CX11, including repackagers and relabelers. The FDA regulates CX11 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CX11 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CX11 supplier is an individual or a company that provides CX11 active pharmaceutical ingredient (API) or CX11 finished formulations upon request. The CX11 suppliers may include CX11 API manufacturers, exporters, distributors and traders.
CX11 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CX11 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CX11 GMP manufacturer or CX11 GMP API supplier for your needs.
A CX11 CoA (Certificate of Analysis) is a formal document that attests to CX11's compliance with CX11 specifications and serves as a tool for batch-level quality control.
CX11 CoA mostly includes findings from lab analyses of a specific batch. For each CX11 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CX11 may be tested according to a variety of international standards, such as European Pharmacopoeia (CX11 EP), CX11 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CX11 USP).
